Clinical Trials Browser

Neurofibromatosis 1 × Other hematologic neoplasm × Clear all

Neurofibromatosis 1, Leukemia, Myelomonocytic, Juvenile

NCT05735717 2025-07-24

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT05849662 2024-11-12

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Phase 1/2 Recruiting

58 enrolled

CNSOther hematologic neoplasm

Neurofibromatosis 1, Leukemia, Myelomonocytic, Juvenile

NCT03981510 2020-11-25

Comparison of Gastrointestinal Motility in Healthy Children and Children With Constipation

Phase NA Unknown

80 enrolled

CNSLymphoidOtherOther hematologic neoplasm

Constipation, Neurofibromatosis 1, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00026780 2020-10-08

Eligibility Screening for a NCI Pediatric Oncology Branch Research Study

Completed

1,720 enrolled

CNSLymphoidOther hematologic neoplasmSarcoma

Neoplasms, Neuroblastoma, Neurofibromatosis 1, Sarcoma, Ewing, Osteosarcoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Comparison of Gastrointestinal Motility in Healthy Children and Children With Constipation

Eligibility Screening for a NCI Pediatric Oncology Branch Research Study